Effects of buprenorphine on opioid craving in comparison to other medications for opioid use disorder: A systematic review of randomized controlled trials-Reference-Cited by-同舟云学术

Effects of buprenorphine on opioid craving in comparison to other medications for opioid use disorder: A systematic review of randomized controlled trials

Published:2023-04 Issue: Volume:139 Page:107589
ISSN:0306-4603
Container-title:Addictive Behaviors
language:en
Short-container-title:Addictive Behaviors

Author:

Baxley Catherine,Borsari Brian,Reavis Jill V.,Manuel Jennifer K.,Herbst Ellen,Becker William,Pennington David,Batki Steven L.,Seal Karen

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Toxicology,Clinical Psychology,Medicine (miscellaneous)

Reference55 articles.

1. Single high-dose buprenorphine for opioid craving during withdrawal;Ahmadi;Trials,2018

2. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders. American Psychiatric Publishing.

3. Opioid detoxification using high doses of buprenorphine in 24 hours: A randomized, double blind, controlled clinical trial;Assadi;Journal of Substance Abuse Treatment,2004

4. Comparative profiles of men and women with opioid dependence: Results from a national multisite effectiveness trial;Back;American Journal of Drug and Alcohol Abuse,2011

5. The influence of anxiety sensitivity on opioid use disorder treatment outcomes;Baxley;Experimental and Clinical Psychopharmacology,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving Engagement in Residential Treatment for Substance Use Disorders: An Integrated Care Quality Improvement Project for Individuals With Mental Health and Substance Use Disorders;The Journal for Nurse Practitioners;2024-10

2. Comparative evaluation of craving, sleep quality, sexual function and quality of life in opioid use disorder patients in remission with buprenorphine/naloxone maintenance treatment;Human Psychopharmacology: Clinical and Experimental;2024-07-14

3. Craving: explanatory models, associated factors, and therapeutic approaches: A systematic review;Psicoespacios;2024-07-11

4. Extended-Release 7-Day Injectable Buprenorphine for Patients With Minimal to Mild Opioid Withdrawal;JAMA Network Open;2024-07-08

5. Dose‐specific clinical outcomes in patients with opioid use disorder treated with 24–32 mg/day of buprenorphine;Addiction;2024-07-08